Solana (NASDAQ:HSDT – Get Free Report) and Heritage Global (NASDAQ:HGBL – Get Free Report) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.
Analyst Ratings
This is a summary of current recommendations for Solana and Heritage Global, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Solana | 1 | 1 | 2 | 0 | 2.25 |
| Heritage Global | 1 | 0 | 1 | 0 | 2.00 |
Solana presently has a consensus target price of $3.75, suggesting a potential upside of 20.58%. Heritage Global has a consensus target price of $3.00, suggesting a potential upside of 122.22%. Given Heritage Global’s higher possible upside, analysts plainly believe Heritage Global is more favorable than Solana.
Volatility & Risk
Profitability
This table compares Solana and Heritage Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Solana | -1,302.78% | -41.86% | -18.53% |
| Heritage Global | -29.63% | 6.12% | 4.69% |
Earnings and Valuation
This table compares Solana and Heritage Global”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Solana | $6.02 million | 31.23 | -$40.89 million | ($30.32) | -0.10 |
| Heritage Global | $50.98 million | 0.92 | $3.59 million | ($0.41) | -3.29 |
Heritage Global has higher revenue and earnings than Solana. Heritage Global is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
18.6% of Solana shares are owned by institutional investors. Comparatively, 33.5% of Heritage Global shares are owned by institutional investors. 14.4% of Solana shares are owned by company insiders. Comparatively, 15.6% of Heritage Global shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Heritage Global beats Solana on 9 of the 14 factors compared between the two stocks.
About Solana
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
About Heritage Global
Heritage Global Inc., together with its subsidiaries, operates as an asset services company with focus on financial and industrial asset transactions. The company operates in three segments: Auction and Liquidation, Refurbishment & Resale, and Brokerage. It provides a suite of market making, acquisitions, refurbishment, dispositions, valuations, and secured lending services. The company focuses on identifying, valuing, acquiring, and monetizing underlying tangible assets. It acts as an adviser, as well as a principal, acquiring, or brokering manufacturing facilities; surplus industrial machinery and equipment; industrial inventories; and charged-off receivable portfolios. The company was formerly known as Counsel RB Capital Inc. and changed its name to Heritage Global, Inc. in August 2013. Heritage Global, Inc. was founded in 1937 and is headquartered in San Diego, California.
Receive News & Ratings for Solana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solana and related companies with MarketBeat.com's FREE daily email newsletter.
